JPS584010B2 - ２，２，２− トリフルオロ −１− クロロエチル − エ−テルノ セイゾウホウホウ - Google Patents
２，２，２− トリフルオロ −１− クロロエチル − エ−テルノ セイゾウホウホウInfo
- Publication number
- JPS584010B2 JPS584010B2 JP49091913A JP9191374A JPS584010B2 JP S584010 B2 JPS584010 B2 JP S584010B2 JP 49091913 A JP49091913 A JP 49091913A JP 9191374 A JP9191374 A JP 9191374A JP S584010 B2 JPS584010 B2 JP S584010B2
- Authority
- JP
- Japan
- Prior art keywords
- ether
- group
- formula
- trifluoro
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- YTNGWZHRZSUNJC-UHFFFAOYSA-N 2-chloro-2-(1-chloro-2,2,2-trifluoroethoxy)-1,1,1-trifluoroethane Chemical compound FC(F)(F)C(Cl)OC(Cl)C(F)(F)F YTNGWZHRZSUNJC-UHFFFAOYSA-N 0.000 title claims description 3
- 125000004432 carbon atom Chemical group C* 0.000 claims description 5
- 125000000217 alkyl group Chemical group 0.000 claims description 4
- 125000002947 alkylene group Chemical group 0.000 claims description 3
- 239000012320 chlorinating reagent Substances 0.000 claims description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 27
- 150000001875 compounds Chemical class 0.000 description 22
- 238000000034 method Methods 0.000 description 11
- 238000006243 chemical reaction Methods 0.000 description 9
- 238000009835 boiling Methods 0.000 description 7
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- 239000003983 inhalation anesthetic agent Substances 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 206010002091 Anaesthesia Diseases 0.000 description 5
- 230000037005 anaesthesia Effects 0.000 description 5
- 230000003444 anaesthetic effect Effects 0.000 description 5
- 238000000921 elemental analysis Methods 0.000 description 5
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 5
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- 239000007795 chemical reaction product Substances 0.000 description 4
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 4
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 4
- UHZYTMXLRWXGPK-UHFFFAOYSA-N phosphorus pentachloride Chemical compound ClP(Cl)(Cl)(Cl)Cl UHZYTMXLRWXGPK-UHFFFAOYSA-N 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 239000007858 starting material Substances 0.000 description 4
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 4
- VCBRTBDPBXCBOR-UHFFFAOYSA-N 2-n,2-n,4-n,4-n,6-n,6-n-hexachloro-1,3,5-triazine-2,4,6-triamine Chemical compound ClN(Cl)C1=NC(N(Cl)Cl)=NC(N(Cl)Cl)=N1 VCBRTBDPBXCBOR-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 3
- 102100039875 Histone H3-7 Human genes 0.000 description 3
- 101001035307 Homo sapiens Histone H3-7 Proteins 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 229910000040 hydrogen fluoride Inorganic materials 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000012074 organic phase Substances 0.000 description 3
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- JVTSHOJDBRTPHD-UHFFFAOYSA-N 2,2,2-trifluoroacetaldehyde Chemical compound FC(F)(F)C=O JVTSHOJDBRTPHD-UHFFFAOYSA-N 0.000 description 2
- MNCPYCODYCPASZ-UHFFFAOYSA-N 2-(2,2-difluoroethenoxy)-1,1-difluoroethene Chemical compound FC(F)=COC=C(F)F MNCPYCODYCPASZ-UHFFFAOYSA-N 0.000 description 2
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- GQPLMRYTRLFLPF-UHFFFAOYSA-N Nitrous Oxide Chemical compound [O-][N+]#N GQPLMRYTRLFLPF-UHFFFAOYSA-N 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 238000005660 chlorination reaction Methods 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 150000002170 ethers Chemical class 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 238000004508 fractional distillation Methods 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 230000029058 respiratory gaseous exchange Effects 0.000 description 2
- XJDNKRIXUMDJCW-UHFFFAOYSA-J titanium tetrachloride Chemical compound Cl[Ti](Cl)(Cl)Cl XJDNKRIXUMDJCW-UHFFFAOYSA-J 0.000 description 2
- MFQDDLJUJRTHFM-UHFFFAOYSA-N 1,1-dichloro-3-(3,3-dichloro-2,2-difluoropropoxy)-2,2-difluoropropane Chemical compound ClC(Cl)C(F)(F)COCC(F)(F)C(Cl)Cl MFQDDLJUJRTHFM-UHFFFAOYSA-N 0.000 description 1
- OHVLMTFVQDZYHP-UHFFFAOYSA-N 1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-2-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]ethanone Chemical compound N1N=NC=2CN(CCC=21)C(CN1CCN(CC1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)=O OHVLMTFVQDZYHP-UHFFFAOYSA-N 0.000 description 1
- JEFLXUBNBFGEIC-UHFFFAOYSA-N 1-chloro-1-(1-chloro-2-fluoroethoxy)-2-fluoroethane Chemical compound FCC(Cl)OC(Cl)CF JEFLXUBNBFGEIC-UHFFFAOYSA-N 0.000 description 1
- BPIUIOXAFBGMNB-UHFFFAOYSA-N 1-hexoxyhexane Chemical compound CCCCCCOCCCCCC BPIUIOXAFBGMNB-UHFFFAOYSA-N 0.000 description 1
- RNFJDJUURJAICM-UHFFFAOYSA-N 2,2,4,4,6,6-hexaphenoxy-1,3,5-triaza-2$l^{5},4$l^{5},6$l^{5}-triphosphacyclohexa-1,3,5-triene Chemical compound N=1P(OC=2C=CC=CC=2)(OC=2C=CC=CC=2)=NP(OC=2C=CC=CC=2)(OC=2C=CC=CC=2)=NP=1(OC=1C=CC=CC=1)OC1=CC=CC=C1 RNFJDJUURJAICM-UHFFFAOYSA-N 0.000 description 1
- QBWUGUNZDJGFCX-UHFFFAOYSA-N 2-chloro-1,1,1-trifluoro-2-methoxyethane Chemical compound COC(Cl)C(F)(F)F QBWUGUNZDJGFCX-UHFFFAOYSA-N 0.000 description 1
- ZGDQTIIOCXICHO-UHFFFAOYSA-N 2-chloro-2-ethoxy-1,1,1-trifluoroethane Chemical compound CCOC(Cl)C(F)(F)F ZGDQTIIOCXICHO-UHFFFAOYSA-N 0.000 description 1
- XVMSFILGAMDHEY-UHFFFAOYSA-N 6-(4-aminophenyl)sulfonylpyridin-3-amine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC=C(N)C=N1 XVMSFILGAMDHEY-UHFFFAOYSA-N 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical class [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 229910019213 POCl3 Inorganic materials 0.000 description 1
- 229910006124 SOCl2 Inorganic materials 0.000 description 1
- 229910003074 TiCl4 Inorganic materials 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 1
- 150000001241 acetals Chemical class 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 229940035674 anesthetics Drugs 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- RQPZNWPYLFFXCP-UHFFFAOYSA-L barium dihydroxide Chemical compound [OH-].[OH-].[Ba+2] RQPZNWPYLFFXCP-UHFFFAOYSA-L 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 235000011148 calcium chloride Nutrition 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 235000011116 calcium hydroxide Nutrition 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- QCMJBECJXQJLIL-UHFFFAOYSA-L chromium(6+);oxygen(2-);difluoride Chemical compound [O-2].[O-2].[F-].[F-].[Cr+6] QCMJBECJXQJLIL-UHFFFAOYSA-L 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- ASWXNYNXAOQCCD-UHFFFAOYSA-N dichloro(triphenyl)-$l^{5}-phosphane Chemical compound C=1C=CC=CC=1P(Cl)(C=1C=CC=CC=1)(Cl)C1=CC=CC=C1 ASWXNYNXAOQCCD-UHFFFAOYSA-N 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 239000003063 flame retardant Substances 0.000 description 1
- 229910052731 fluorine Chemical class 0.000 description 1
- 239000011737 fluorine Chemical class 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 239000003193 general anesthetic agent Substances 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- -1 hydrogen halides Chemical class 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- RFKMCNOHBTXSMU-UHFFFAOYSA-N methoxyflurane Chemical compound COC(F)(F)C(Cl)Cl RFKMCNOHBTXSMU-UHFFFAOYSA-N 0.000 description 1
- 229940035363 muscle relaxants Drugs 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 239000003158 myorelaxant agent Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 235000013842 nitrous oxide Nutrition 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 210000004738 parenchymal cell Anatomy 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- AOJFQRQNPXYVLM-UHFFFAOYSA-N pyridin-1-ium;chloride Chemical group [Cl-].C1=CC=[NH+]C=C1 AOJFQRQNPXYVLM-UHFFFAOYSA-N 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- HFFLGKNGCAIQMO-UHFFFAOYSA-N trichloroacetaldehyde Chemical compound ClC(Cl)(Cl)C=O HFFLGKNGCAIQMO-UHFFFAOYSA-N 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
- C07C43/04—Saturated ethers
- C07C43/12—Saturated ethers containing halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
- C07C43/04—Saturated ethers
- C07C43/12—Saturated ethers containing halogen
- C07C43/123—Saturated ethers containing halogen both carbon chains are substituted by halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
- C07C43/14—Unsaturated ethers
- C07C43/17—Unsaturated ethers containing halogen
- C07C43/174—Unsaturated ethers containing halogen containing six-membered aromatic rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Anesthesiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2340561A DE2340561C2 (de) | 1973-08-10 | 1973-08-10 | 2.2.2-Trifluor-1-chloräthyl-äther und Verfahren zu ihrer Herstellung sowie Inhalations-Anästhetikum, das einen dieser Stoffe enthält |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5076008A JPS5076008A (de) | 1975-06-21 |
| JPS584010B2 true JPS584010B2 (ja) | 1983-01-24 |
Family
ID=5889423
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP49091913A Expired JPS584010B2 (ja) | 1973-08-10 | 1974-08-10 | ２，２，２− トリフルオロ −１− クロロエチル − エ−テルノ セイゾウホウホウ |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US3980714A (de) |
| JP (1) | JPS584010B2 (de) |
| AT (1) | AT342557B (de) |
| BE (1) | BE818751A (de) |
| CA (1) | CA1041124A (de) |
| CH (1) | CH608776A5 (de) |
| DE (1) | DE2340561C2 (de) |
| DK (1) | DK426874A (de) |
| ES (1) | ES428969A1 (de) |
| FR (1) | FR2239992B1 (de) |
| GB (1) | GB1458599A (de) |
| NL (1) | NL7410484A (de) |
| SE (1) | SE7410165L (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4762856A (en) * | 1987-02-02 | 1988-08-09 | Boc, Inc. | Anesthetic composition and method of using the same |
| EP0352034A3 (de) * | 1988-07-18 | 1991-04-10 | Boc, Inc. | Verfahren und Zwischenverbindung zur Herstellung von CHF2OCHFCF3 |
| US5114715A (en) * | 1990-11-29 | 1992-05-19 | Sepracor Inc. | Methods of use and compositions of (s)-isoflurane and (s)-desflurane |
| US5114714A (en) * | 1990-11-29 | 1992-05-19 | Sepracor, Inc. | Methods of use and compositions of (r)-isoflurane and (r)-desflurane |
| US5350497A (en) * | 1993-05-21 | 1994-09-27 | E. I. Du Pont De Nemours And Company | Production of perfluoro(alkyl vinyl ethers) |
| US11484577B2 (en) | 2016-02-15 | 2022-11-01 | Inserm (Institut National De La Sante Et De La Recherche Medicale) | Methods and pharmaceutical compositions for the treatment of post-operative cognitive dysfunction |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3535388A (en) * | 1969-05-12 | 1970-10-20 | Air Reduction | 1-chloro-2,2,2-trifluoroethyl difluoromethyl ether |
| US3535425A (en) * | 1969-12-18 | 1970-10-20 | Air Reduction | 1-chloro-2,2,2-trifluoroethyl difluoromethyl ether as an anesthetic agent |
| US3764706A (en) * | 1971-08-11 | 1973-10-09 | Airco Inc | Inhalation anesthetic |
-
1973
- 1973-08-10 DE DE2340561A patent/DE2340561C2/de not_active Expired
-
1974
- 1974-08-05 NL NL7410484A patent/NL7410484A/xx not_active Application Discontinuation
- 1974-08-05 ES ES428969A patent/ES428969A1/es not_active Expired
- 1974-08-07 GB GB3485574A patent/GB1458599A/en not_active Expired
- 1974-08-08 FR FR7427626A patent/FR2239992B1/fr not_active Expired
- 1974-08-08 SE SE7410165A patent/SE7410165L/xx unknown
- 1974-08-08 US US05/495,898 patent/US3980714A/en not_active Expired - Lifetime
- 1974-08-09 CA CA206,866A patent/CA1041124A/en not_active Expired
- 1974-08-09 DK DK426874A patent/DK426874A/da not_active Application Discontinuation
- 1974-08-09 AT AT655674A patent/AT342557B/de not_active IP Right Cessation
- 1974-08-09 CH CH7410911A patent/CH608776A5/xx not_active IP Right Cessation
- 1974-08-10 JP JP49091913A patent/JPS584010B2/ja not_active Expired
- 1974-08-12 BE BE147522A patent/BE818751A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FR2239992B1 (de) | 1978-07-21 |
| JPS5076008A (de) | 1975-06-21 |
| SE7410165L (de) | 1975-02-11 |
| DK426874A (de) | 1975-04-21 |
| AT342557B (de) | 1978-04-10 |
| ATA655674A (de) | 1977-08-15 |
| US3980714A (en) | 1976-09-14 |
| CH608776A5 (de) | 1979-01-31 |
| GB1458599A (en) | 1976-12-15 |
| BE818751A (fr) | 1975-02-12 |
| FR2239992A1 (de) | 1975-03-07 |
| CA1041124A (en) | 1978-10-24 |
| NL7410484A (nl) | 1975-02-12 |
| ES428969A1 (es) | 1977-01-16 |
| DE2340561A1 (de) | 1975-02-27 |
| DE2340561C2 (de) | 1982-12-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2593571B2 (ja) | １，２，２，２―テトラフルオロエチルジフルオロメチルエーテルの製造方法 | |
| JP4166870B2 (ja) | セボフルランの製造法 | |
| ES2337553T3 (es) | Procedimiento para la preparacion de cetonas fluoradas. | |
| US3080430A (en) | Fluorine-containing compounds | |
| US3749791A (en) | Fluorine or chlorine-substituted 2,2-bis(trifluoromethyl)-1,3-dioxolane anesthetics | |
| US3659023A (en) | Method of inducing anesthesia with 2-bromo-1 1 2 3 3-pentafluoropropane | |
| US3976788A (en) | Antipsychotic agents | |
| HOFFMANN | ALIPHATIC FLUORIDES. II. 1-HALOGENO-ι-FLUOROALKANES1 | |
| JPS584010B2 (ja) | ２，２，２− トリフルオロ −１− クロロエチル − エ−テルノ セイゾウホウホウ | |
| US3689571A (en) | Fluorinated ether | |
| US3535425A (en) | 1-chloro-2,2,2-trifluoroethyl difluoromethyl ether as an anesthetic agent | |
| US3981927A (en) | 1,2,2,2-Tetrafluoroethyl ethers and process for preparing them | |
| US4088701A (en) | 1,2,2,2-tetrafluoroethyl-fluoromethyl ether and process for preparing it | |
| KR100211776B1 (ko) | 플루오르화 화합물의 제조방법 | |
| JPH0637400B2 (ja) | フルオロ脱カルボキシル化方法 | |
| US3499089A (en) | Method of inducing anesthesia with 2-halo-1,1,1,3,3-pentafluoropropanes | |
| RU2268876C2 (ru) | Способ получения фторированного поливалентного карбонильного соединения | |
| US4972040A (en) | Process for the preparation of CHF2 OCHFCF3 | |
| JP3423314B2 (ja) | クロロフルオロエーテル組成物およびそれらの製造 | |
| JPH0660119B2 (ja) | ＣＨＦ▲下２▼ＯＣＨＦＣＦ▲下３▼及び、ＣＨＦ▲下２▼ＯＣＨＣ▲ｌ▼ＣＦ▲下３▼の製造方法及びこれらの製造のための新規な中間体 | |
| US3666864A (en) | Compositions and methods for producing anesthesia | |
| Sawaguchi et al. | Deiodinative fluorination of alkyl iodide with p-iodotoluene difluoride | |
| US3943256A (en) | Antipsychotic agents | |
| IL32586A (en) | 1,3-polyhalo-2-propyl methyl and halomethyl ethers and their preparation | |
| US3764706A (en) | Inhalation anesthetic |